| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
Bleomycin |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-05 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
6e-05 |